TITLE

Innovation Rebound

PUB. DATE
September 2011
SOURCE
Pharmaceutical Representative;Sep2011, Vol. 41 Issue 9, p9
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the decline of new product approvals in the pharmaceutical industry of the U.S.
ACCESSION #
65353996

 

Related Articles

  • Untitled.  // Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p11 

    The article offers news briefs related to the pharmaceutical industry in the U.S. including the approval of the Food and Drug Administration (FDA) on the production and distribution of influenza vaccines in the country, the approval to use Boostrix vaccine from GlaxoSmithKline in tetanus...

  • Pharma: Other News To Note.  // BioWorld Today;7/16/2012, Vol. 23 Issue 136, p3 

    This section offers news briefs on the U.S. pharmaceutical industry including the first Food and Drug Administration (FDA) approval received by Par Pharmaceutical Cos. Inc. for Labetalol HCI tablets and the FDA approval given to the abbreviated new drug application of Watson Pharmaceuticals Inc....

  • Market watch: Upcoming market catalysts in Q3 2011. Fong, Stacey // Nature Reviews Drug Discovery;Jul2011, Vol. 10 Issue 7, p482 

    The article offers information related to pharmaceutical industry in the U.S. in the third quarter of 2011. It says that U.S. has approved brentuximab vedotin in treating relapsed or refractory systemic anaplastic large cell lymphoma (ALCL) and relapsed or refractory Hodgkin's lymphoma as well...

  • Pharma: Other News To Note.  // BioWorld Today;11/13/2012, Vol. 23 Issue 221, p11 

    This section offers news briefs on the pharmaceutical industry in the U.S. as of November 13, 2012, which include the deal between Foundation Medicine Inc. and AstraZeneca, approval of Janssen Therapeutics' Prezista and a new drug application from Watson Pharmaceuticals.

  • UNITED STATES PHARMACEUTICALS.  // Acquisdata Industry SnapShot: United States - Pharmaceuticals;8/ 7/2014, Issue 1742, p1 

    The article reports on the pharmaceutical industry in the U.S. as well as the approval of Jardiance tablets by the Food and Drug Administration (FDA) and the increase in Baxter International Inc.'s earnings.

  • India Drugs Inquiry Could Prompt New U.S. Scrutiny. VISWANATHA, ARUNA // News India Times;05/18/2012, Vol. 43 Issue 20, p17 

    The article reports on the potential for global drug companies to undergo stricter drug approval process in the U.S. in 2012 after the emergence of an Indian report which revealed the collusion between the Central Drugs Standard Control Organization and pharmaceutical firms.

  • Pipeline.  // Medical Marketing & Media;Nov2011, Vol. 46 Issue 11, p10 

    The article offers news briefs related to U.S. pharmaceutical industry including the approval of Ferriprox (deferiprone) for the treatment of iron overload, the approval of Eli Lilly's Cialis (tadalafil) for Benign Prostatic Hyperplasia, and the launching of Archimedes Pharma's Lazanda (fentanyl).

  • Pipeline.  // Medical Marketing & Media;Feb2016, Vol. 51 Issue 2, p16 

    The article offers information on the pharmaceutical industry in the U.S. including the partnership between Sanofi and Innate Pharma, the move of Roche to pursue approval from the Food and Drug Administration (FDA) for the atezolizumab drug, and a deal between Mylan and Momenta Pharmaceuticals.

  • Pipeline 2011. Perry, Leah E. // Drug Topics;Jan2011, Vol. 155 Issue 1, p30 

    The article offers forecasts on the trends in the pharmaceutical industry for 2011 in the U.S. It reveals that drug development has continued to drop compared to the successful period in previous years. It also shows the slow-moving rate at which the Food and Drug Administration (FDA) approves...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics